Wolgen paints things a bit different then I would (process in Europe) The main update I noticed on first read are commercially available in austria and netherlands and still available under the access schemes in Italy and Switzerland (but no mention if its the commercial price so I'd guess its not)
I don't know if its deliberate or incompetence but they mention the EPP Workshop/conference FDA is holding October 24th as invitees only when it certainly appears to be open for the public http://www.fda.gov/Drugs/NewsEvents/ucm501389.htm
If you follow the link on the page you can register and then get an email with a link to the webcast of the event when its available.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM